Urinary Bladder Cancer: Preoperative Nodal Staging with Ferumoxtran-10–enhanced MR Imaging

Authors:
  • MHMukesh G. Harisinghani
    Mukesh G. Harisinghani
  • MTMatthias Taupitz
    Matthias Taupitz
  • GJGerrit J. Jager
    Gerrit J. Jager
  • JWJ. Alfred Witjes
    J. Alfred Witjes
  • PMPeter F. Mulders
    Peter F. Mulders
  • CKChristina A. Hulsbergen van de Kaa
    Christina A. Hulsbergen van de Kaa
  • DKD. Kaufmann
    D. Kaufmann
  • JBJelle O. Barentsz
    Jelle O. Barentsz

Abstract
PURPOSE: To prospectively evaluate ferumoxtran-10–enhanced magnetic resonance (MR) imaging for nodal staging in patients with urinary bladder cancer. MATERIALS AND METHODS: Fifty-eight patients with proved bladder cancer were enrolled. Results of MR imaging performed before and after injection of ferumoxtran-10 were compared with histopathologic results in surgically removed lymph nodes. High-spatial-resolution three-dimensional T1-weighted magnetization-prepared rapid acquisition gradient-echo (voxel size, 1.4 × 1.4 × 1.4 mm) and T2*-weighted gradient-echo (voxel size, 0.8 × 0.8 × 3.0 mm) sequences were performed before and 24 hours after injection of ferumoxtran-10 (2.6 mg iron per kilogram of body weight). On precontrast images, lymph nodes were defined as malignant by using size and shape criteria (round node, >8 mm; oval, >10 mm axial diameter). On postcontrast images, nodes were considered benign if there was homogeneous decrease in signal intensity and malignant if decrease was absent or heterogene...

This publication has 28 references indexed in Scilit: